Fundraising Fox

Nanopath

Cambridge, US · Founded 2019 · Delaware corporation · 2 known investors

nanopath.com ↗
Biotechin /nanopathdx@nanopathdx

Founders & leadership

AB
Alison BurklundExecutive Officer, Director30 Under 30 2023
AT
Amogha TadimetyExecutive Officer, Director
AS
Aaron SandoskiDirector
JC
Jeff CroweDirector

Investors · 2

Service Provider CapitalVail
Norwich VenturesreportedWalthamvia Aaron Sandoski · board

Reported raises · per SEC filings

Form D private placements
▶$5.3MraisedFeb 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alison BurklundExecutive Officer, Director
  • Aaron SandoskiDirector
  • Amogha TadimetyExecutive Officer, Director
  • Jeff CroweDirector
Offering amount
$6M
Amount sold
$5.3M
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedAug 2022 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey CroweDirector
  • Alison BurklundExecutive Officer, Director
  • Amogha TadimetyExecutive Officer, Director
Offering amount
$10M
Amount sold
$10M
First sale
Jun 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.